Biochemical monitoring of mTOR inhibitor-based immunosuppression following kidney transplantation: A novel approach for tailored immunosuppressive therapy

Antitumor Efficacy of Intermittent Treatment Schedules with the Rapamycin Derivative RAD001 Correlates with Prolonged Inactivation of Ribosomal Protein S6 Kinase 1 in Peripheral Blood Mononuclear Cells

Anne Boulay, Sabine Zumstein-Mecker, Christine Stephan et al. · Cancer Research · 2004 · 319 citations · Full text

Medicine, Oncology, Pharmacology +14

Long-Term Benefits with Sirolimus-Based Therapy after Early Cyclosporine Withdrawal

Henri Kreis, Rainer Oberbauer, Josep M. Campistol et al. · Journal of the American Society of Nephrology · 2004 · 226 citations

Medicine, Nephrology, Pharmacology +14

Pharmacodynamic Evaluation of CCI-779, an Inhibitor of mTOR, in Cancer Patients.

Josep Maria Peralba, Linda A. deGraffenried, William E. Friedrichs et al. · PubMed · 2003 · 179 citations

Medicine, Oncology, Pharmacology +17

A prospective randomized multicenter study of tacrolimus in combination with sirolimus in renal-transplant recipients

Johannes P. van Hooff, Jean‐Paul Squifflet, Zbigniew Włodarczyk et al. · Transplantation · 2003 · 67 citations

Medicine, Nephrology, Pharmacotherapy +17

Blockage of 2-Deoxy-<scp>d</scp>-Ribose-Induced Angiogenesis with Rapamycin Counteracts a Thymidine Phosphorylase-Based Escape Mechanism Available for Colon Cancer under 5-Fluorouracil Therapy

Hendrik Seeliger, Markus Guba, Gudrun E. Koehl et al. · Clinical Cancer Research · 2004 · 66 citations

Medicine, Oncology, Pharmacology +17